TraumaShield
Request a briefing
FDA-approved agent·Novel second medical use·Post-trauma intervention·Fear-memory consolidation modulation·Critical window deployment·PTSD prevention·Medical device + pharma convergence·IP protected·505(b)(2) pathway·FDA-approved agent·Novel second medical use·Post-trauma intervention·Fear-memory consolidation modulation·Critical window deployment·PTSD prevention·Medical device + pharma convergence·IP protected·505(b)(2) pathway·
Request a briefing
TraumaShield
Request a briefing
Legal

Cookie Notice

How this website uses cookies and similar technologies.

Last updated: October 31, 2026

Our approach

This website does not use advertising, tracking or analytics cookies, and it does not set cookies of its own to identify you. The only item it stores in your browser is a single session-storage entry that remembers you closed the on-screen notice, so it is not shown again during your visit. It contains no personal information and is deleted when you close the browser tab.

Third-party services

To display the site, your browser connects to a small number of service providers:

  • Netlify hosts and delivers the website, receives inquiry-form submissions (Netlify Forms), and may use strictly necessary technologies to do so securely.
  • Google Fonts delivers the site’s typefaces and receives your IP address when fonts load.
  • FormSubmit is used only as a backup if Netlify Forms is unavailable, and receives the content of the inquiry form when you choose to send it.

These providers process data under their own privacy policies. For how we handle personal information, see our Privacy Policy.

Managing cookies

You can block or delete cookies through your browser settings at any time. Because this site does not rely on cookies, blocking them will not affect how it works.

Changes and contact

If we introduce cookies in the future, we will update this notice and, where required, ask for your consent first. Questions can be sent to david@traumashield.co.